Lupus Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
This trial has four different groups. A person may fit into one of the following:
Group 1 – People with lupus (SLE) and kidney involvement:
- Adults aged 18 or older
- Diagnosed with lupus (SLE) based on recognised 2019 international classification criteria
- Has positive autoantibodies (specific proteins the immune system makes that can indicate lupus), along with a medical history and physical examination consistent with lupus
- Has been referred for a kidney biopsy (a procedure where a small sample of kidney tissue is taken for testing)
Group 2 – People with lupus (SLE) and no signs of kidney disease:
- Adults aged 18 or older
- Diagnosed with lupus (SLE) based on recognised 2019 international classification criteria
- Has positive autoantibodies, along with a medical history and physical examination consistent with lupus
- Has normal kidney function levels in the blood
- Has low levels of protein in the urine, indicating the kidneys are not leaking protein
Group 3 – Healthy volunteers:
- Adults aged 18 or older
- No known kidney disease
Group 4 – Biopsy control group (people having a kidney biopsy for reasons other than lupus):
- Adults aged 18 or older
- Does not have positive autoantibodies or abnormal immunoglobulins (certain immune system proteins)
- Has been referred for a kidney biopsy
Who may not be able to join:
Applies to all groups:
- People who are unable or unwilling to give informed consent to participate in the study
- People with serious other health conditions that doctors consider could affect the study results
Additional exclusions for healthy volunteers (Group 3):
- People who have abnormal levels of protein in their urine, which may suggest a kidney problem
- People who have positive autoantibodies
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Anne F Christensen, Chief of Medicine, MD, phd, Sygehus Lillebaelt, Kolding Hospitl
Phone: 4530281347
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Correlation between kidney biopsy and urinay extracellular vesicles; Complement activation in urinary extracellular vesicles
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.